Status:
COMPLETED
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
Statens Serum Institut
Research Center for Vitamins and Vaccines
Conditions:
Measles Vaccination
Oral Polio Vaccine
Eligibility:
All Genders
Up to 59 years
Phase:
PHASE4
Brief Summary
The world is set on eradicating measles and polio infections in the coming decade. Once both infections are under control, campaigns with measles and oral polio vaccines will be phased out. This might...
Eligibility Criteria
Inclusion
- Children aged 0-59 months living with families registered in the rural Bandim Health Project Health and Demographic Surveillance Site are included, provided a parent/guardian consent.
Exclusion
- the child has temperature \> 39.0◦C or a severe acute illness as defined by the examining nurse
- OR
- the child has as a mid upper arm circumference \< 110 mm and is older than 6 months (most feasible local indicator of AIDS and chronic immunosuppressive disease)
- OR
- the child has experienced a severe allergic reaction after previous vaccination, drug or food.
- OR
- the child is enrolled in an ongoing study of Bacillus Calmette Guerin vaccine and is \< 2 months old
- OR
- For the RECAMP-MV trial: the child is enrolled in RECAMP-OPV
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
28612 Patients enrolled
Trial Details
Trial ID
NCT03460002
Start Date
November 1 2016
End Date
August 1 2022
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Guinea-Bissau